| Dr Juleann C Gandara, MD | |
|
939 Caroline St, Port Angeles, WA 98362-3909 | |
| (360) 417-7000 | |
| Not Available |
| Full Name | Dr Juleann C Gandara |
|---|---|
| Gender | Female |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 939 Caroline St, Port Angeles, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497723837 | NPI | - | NPPES |
| P00177918 | Other | RAILROAD MEDICARE | |
| 9161GA | Other | REGENCE BLUE SHIELD RIDER | |
| 8104945 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD00020046 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Juleann C Gandara, MD 939 Caroline St, Port Angeles, WA 98362-3909 Ph: (360) 417-7000 | Dr Juleann C Gandara, MD 939 Caroline St, Port Angeles, WA 98362-3909 Ph: (360) 417-7000 |
News Archive
The results of a randomized, double-blind, placebo-controlled clinical trial showed that Cognizin citicoline (Jarrow Formulas) was effective at reducing cocaine use, based on urine drug screens, in patients with bipolar disorder and cocaine dependence. The study, published in the American Journal of Psychiatry in Advance, included a total of 130 outpatients with bipolar I disorder and cocaine dependence, who received either Cognizin citicoline or placebo add-on therapy for 12 weeks.
Pharmacyclics, Inc. today announced longer-term data from a Phase II investigator-initiated study showing Waldenstrom's macroglobulinemia (WM) patients treated with IMBRUVICA (ibrutinib) experienced sustained disease control with an overall response rate (ORR) of 91% after a median of 19.1 months of treatment and a 2-year overall survival (OS) rate of 95%.
Breast reduction surgery produces measurable improvements in several important areas of health and quality of life, reports a study in the August issue of Plastic and Reconstructive Surgery-, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder based on multiple standard measures of outcome for depression.
› Verified 7 days ago
Dr. Kirk A Cole, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 939 Caroline St, Port Angeles, WA 98362 Phone: 360-417-7000 | |
Dr. Benjamin P Pisciotta, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 939 Caroline St, Port Angeles, WA 98362 Phone: 360-417-7000 | |
Dr. Lauren Kathleen Fetty, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 939 Caroline St, Port Angeles, WA 98362 Phone: 360-565-9003 Fax: 360-565-9001 | |
Dr. Sherrie L Chatzkel, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 939 Caroline St, Port Angeles, WA 98362 Phone: 360-417-7000 | |
Dr. Clare S Bertucio, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 939 Caroline St, Port Angeles, WA 98362 Phone: 360-417-7000 |